Kelman-Lazarov Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,176
Closed -$266K 111
2024
Q3
$266K Hold
9,176
0.05% 94
2024
Q2
$257K Buy
9,176
+94
+1% +$2.59K 0.05% 94
2024
Q1
$252K Sell
9,082
-93
-1% -$2.58K 0.05% 94
2023
Q4
$264K Sell
9,175
-489
-5% -$14.8K 0.06% 89
2023
Q3
$321K Sell
9,664
-90
-0.9% -$3.18K 0.08% 77
2023
Q2
$358K Buy
9,754
+283
+3% +$11K 0.09% 78
2023
Q1
$386K Buy
9,471
+754
+9% +$32.6K 0.1% 69
2022
Q4
$447K Sell
8,717
-524
-6% -$25.1K 0.13% 61
2022
Q3
$404K Hold
9,241
0.14% 57
2022
Q2
$485K Sell
9,241
-421
-4% -$21.5K 0.16% 51
2022
Q1
$500K Hold
9,662
0.17% 51
2021
Q4
$571K Buy
9,662
+1,528
+19% +$75.7K 0.18% 49
2021
Q3
$350K Hold
8,134
0.12% 60
2021
Q2
$319K Sell
8,134
-768
-9% -$29.9K 0.11% 65
2021
Q1
$323K Hold
8,902
0.12% 64
2020
Q4
$328K Sell
8,902
-481
-5% -$17.6K 0.13% 59
2020
Q3
$327K Sell
9,383
-628
-6% -$22K 0.15% 57
2020
Q2
$311K Sell
10,011
-1,596
-14% -$54.2K 0.14% 58
2020
Q1
$359K Sell
11,607
-559
-5% -$19K 0.19% 51
2019
Q4
$452K Sell
12,166
-413
-3% -$14.7K 0.2% 58
2019
Q3
$429K Sell
12,579
-86
-0.7% -$3.13K 0.21% 64
2019
Q2
$521K Hold
12,665
0.27% 55
2019
Q1
$510K Buy
12,665
+1,403
+12% +$56.2K 0.27% 62
2018
Q4
$466K Sell
11,262
-1,564
-12% -$64.9K 0.29% 63
2018
Q3
$536K Sell
12,826
-385
-3% -$14.8K 0.31% 67
2018
Q2
$455K Hold
13,211
0.24% 81
2018
Q1
$445K Sell
13,211
-5,902
-31% -$203K 0.24% 83
2017
Q4
$657K Buy
19,113
+1,255
+7% +$42.8K 0.34% 70
2017
Q3
$605K Hold
17,858
0.32% 77
2017
Q2
$569K Buy
17,858
+5,902
+49% +$186K 0.31% 78
2017
Q1
$388K Sell
11,956
-969
-7% -$30.6K 0.25% 83
2016
Q4
$398K Sell
12,925
-4,503
-26% -$137K 0.22% 87
2016
Q3
$558K Sell
17,428
-167
-0.9% -$5.58K 0.32% 76
2016
Q2
$594K Hold
17,595
0.34% 76
2016
Q1
$501K Buy
+17,595
New +$503K 0.29% 84

Other funds holding PFE